CY1118203T1 - Κατιονika παραγωγα βακτηριοχλωροφυλλης και χρησεις αυτων - Google Patents

Κατιονika παραγωγα βακτηριοχλωροφυλλης και χρησεις αυτων

Info

Publication number
CY1118203T1
CY1118203T1 CY20161101097T CY161101097T CY1118203T1 CY 1118203 T1 CY1118203 T1 CY 1118203T1 CY 20161101097 T CY20161101097 T CY 20161101097T CY 161101097 T CY161101097 T CY 161101097T CY 1118203 T1 CY1118203 T1 CY 1118203T1
Authority
CY
Cyprus
Prior art keywords
group
groups
bchls
converted
positively charged
Prior art date
Application number
CY20161101097T
Other languages
English (en)
Inventor
Avigdor Scherz
Alexander Brandis
Yoram Salomon
Doron Eren
Avraham Cohen
Original Assignee
Yeda Research And Development Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Research And Development Co., Ltd. filed Critical Yeda Research And Development Co., Ltd.
Publication of CY1118203T1 publication Critical patent/CY1118203T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D229/00Heterocyclic compounds containing rings of less than five members having two nitrogen atoms as the only ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/409Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/555Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

Η εφεύρεση παρέχει κατιονικά τετρακυκλικά και πεντακυκλικά παράγωγα βακτηριοχλωροφύλλης (Bchls) που περιέχουν τουλάχιστον μία θετικώς φορτισμένη ομάδα ή/και τουλάχιστον μια βασική ομάδα, η οποία μετατρέπεται προς θετικώς φορτισμένη ομάδα υπό φυσιολογικές συνθήκες, κατά προτίμηση Bchls που έχουν ομάδες ωνίου προερχόμενες από αλειφατική ή ετεροκυκλική ρίζα που περιέχει Ν όπως αμμώνιο, γουανιδίνιο, ιμιδαζόλιο, πυριδίνιο, και τα παρόμοια τους ή ομάδα φωσφονίου, αρσονίου, οξονίου, σουλφονίου, σεληνονίου, τελλουρονίου, στιβονίου, ή βισμουθονίου ή βασική ομάδα η οποία μετατρέπεται προς τέτοιες ομάδες ωνίου υπό φυσιολογικές συνθήκες, οι εν λόγω δε ομάδες είναι δεσμευμένες προς μία ή περισσότερες από τις θέσεις 173, 133 και 32 του Bchl μορίου μέσω εστέρα ή δεσμού αμιδίου. Τα Bchls είναι χρήσιμα για φωτοδυναμική θεραπεία και διάγνωση.
CY20161101097T 2004-06-07 2016-10-27 Κατιονika παραγωγα βακτηριοχλωροφυλλης και χρησεις αυτων CY1118203T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57719604P 2004-06-07 2004-06-07
EP05749886.7A EP1753457B8 (en) 2004-06-07 2005-06-07 Cationic bacteriochlorophyll derivatives and uses thereof

Publications (1)

Publication Number Publication Date
CY1118203T1 true CY1118203T1 (el) 2017-06-28

Family

ID=35044538

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20161101099T CY1118194T1 (el) 2004-06-07 2016-10-27 Κατιονikα παραγωγα βακτηριοχλωροφυλλης και χρησεις αυτων
CY20161101097T CY1118203T1 (el) 2004-06-07 2016-10-27 Κατιονika παραγωγα βακτηριοχλωροφυλλης και χρησεις αυτων

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CY20161101099T CY1118194T1 (el) 2004-06-07 2016-10-27 Κατιονikα παραγωγα βακτηριοχλωροφυλλης και χρησεις αυτων

Country Status (19)

Country Link
US (1) US8207154B2 (el)
EP (2) EP1753457B8 (el)
JP (1) JP5372371B2 (el)
KR (1) KR101191700B1 (el)
CN (1) CN1980661B (el)
AU (1) AU2005251556B2 (el)
BR (1) BRPI0511909A (el)
CA (1) CA2569675C (el)
CY (2) CY1118194T1 (el)
DK (2) DK2322173T3 (el)
ES (2) ES2602204T3 (el)
HU (2) HUE031075T2 (el)
MX (1) MXPA06014326A (el)
NO (2) NO339304B1 (el)
NZ (1) NZ551845A (el)
PT (2) PT1753457T (el)
RU (1) RU2397172C2 (el)
WO (1) WO2005120573A2 (el)
ZA (1) ZA200700169B (el)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2008665A1 (fr) * 2007-06-25 2008-12-31 Steba Biotech N.V. Formulation injectable pour thérapie photodynamique
WO2009107139A1 (en) 2008-02-27 2009-09-03 Yeda Research And Development Co. Ltd Rgd-(bacterio)chlorophyll conjugates for photodynamic therapy and imaging of necrotic tumors
CA2846011C (en) 2011-08-23 2019-10-15 Yeda Research And Development Co.Ltd. (bacterio)chlorophyll photosensitizers for treatment of eye diseases and disorders
PL2971026T3 (pl) 2013-03-11 2021-06-14 Tookad Ip Sarl Sposób wytwarzania bakteriochlorofilu a
RU2548675C9 (ru) * 2013-05-29 2015-11-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Московский государственный университет тонких химических технологий имени М.В. Ломоносова" (МИТХТ им. М.В. Ломоносова) Аминоамиды в ряду бактериохлорофилла a, обладающие фотодинамической активностью, и способ их получения
JP6218073B2 (ja) * 2013-11-26 2017-10-25 国立大学法人群馬大学 細胞・組織内酸素濃度測定のための高感度近赤外りん光イリジウム錯体
RU2549953C2 (ru) * 2013-12-25 2015-05-10 Федеральное государственное унитарное предприятие Государственный научный центр "Научно-исследовательский институт органических полупродуктов и красителей" (ФГУП "ГНЦ "НИОПИК") Фотосенсибилизатор для фотодинамической терапии
RU2610566C1 (ru) * 2015-09-17 2017-02-13 Сергей Сергеевич Брусов Способ фотодинамической терапии локальных очагов инфекции
CN105424857A (zh) * 2015-12-01 2016-03-23 浙江汇能生物股份有限公司 一种二甲基半胱胺盐酸盐的高效液相色谱分析方法
US10836774B2 (en) 2016-11-30 2020-11-17 North Carolina State University Methods for making bacteriochlorin macrocycles comprising an annulated isocyclic ring and related compounds
WO2022115443A1 (en) * 2020-11-24 2022-06-02 The Regents Of The University Of California Mitochondria targeting quinolinium-drug conjugates and their self-assembling nanoformulations for cancer therapy
CN115093422B (zh) * 2022-06-15 2023-06-20 西北工业大学 一种基于代谢标记策略的新型光敏剂及其制备方法和应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3050296A (en) * 1960-12-19 1962-08-21 Trimborn Hans Transport roller for industrial furnaces
US3203888A (en) * 1961-04-24 1965-08-31 Exxon Research Engineering Co Treating athabaska sands utilizing a flotation gas
DE2018970A1 (de) 1970-04-21 1971-11-11 Badische Anilin- & Soda Fabrik AG, 6700 Ludwigshafen Verfahren zur Herstellung von beta-Aminoäthylsulfoniumverbindungen
US5330741A (en) * 1992-02-24 1994-07-19 The Regents Of The University Of California Long-wavelength water soluble chlorin photosensitizers useful for photodynamic therapy and diagnosis of tumors
US5744598A (en) * 1992-06-19 1998-04-28 University Of Toledo Imines of porphyrins, of porphyrin derivatives, and of related compounds, and pharmaceutical compositions containing such imines
IL102645A (en) 1992-07-26 1998-02-22 Yeda Res & Dev Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them
US6147195A (en) 1993-07-26 2000-11-14 Yeda Research And Development Co., Ltd. Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them
IL116126A0 (en) 1995-11-24 1996-01-31 Yeda Res & Dev Process for the preparation of bacteriochlorophyllis some novel compounds of this type and pharmaceutical compositions comprising them
US5770730A (en) 1996-03-08 1998-06-23 Health Research, Inc. Synthesis of carbodimide analogs of chlorins and bacteriochlorins and their use for diagnosis and treatment of cancer
HU228208B1 (en) 1998-12-09 2013-01-28 Yeda Res & Dev Palladium-substituted bacteriochlorophyll derivatives and use thereof
IL133253A0 (en) * 1999-12-01 2001-04-30 Yeda Res & Dev Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them
US6573258B2 (en) 2000-09-27 2003-06-03 Frontier Scientific, Inc. Photodynamic porphyrin antimicrobial agents
AU2002312154B2 (en) * 2001-06-01 2008-05-15 Biolitec Pharma Marketing Ltd Water-soluble porphyrin derivatives for photodynamic therapy, their use and manufacture
US20030203888A1 (en) * 2001-06-06 2003-10-30 Boyle Ross William Chromophores
AU2002336637A1 (en) 2001-10-03 2003-04-14 Miravant Pharmaceuticals, Inc. Chlorin photosensitizing agents for use in photodynamic therapy
CA2462508A1 (en) 2001-10-03 2003-04-10 Miravant Pharmaceuticals, Inc. Photosensitizing carbamate derivatives
DE10154436A1 (de) 2001-11-07 2003-05-15 Rodotech Gmbh pyro-Bakteriopheophorbidderivate
GB0130778D0 (en) * 2001-12-21 2002-02-06 Catalyst Biomedica Ltd Novel compounds
BR0304716A (pt) 2002-05-08 2004-07-13 Yeda Res & Dev Método para formação de imagens de mri-bold on line, sensibilizada
WO2004002476A2 (en) * 2002-06-27 2004-01-08 Health Research, Inc. Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy
IL152900A0 (en) 2002-11-17 2003-06-24 Yeda Res & Dev Water-soluble bacteriochlorophyll derivatives and their pharmaceutical uses

Also Published As

Publication number Publication date
EP1753457B8 (en) 2016-09-21
ES2602204T3 (es) 2017-02-20
CN1980661A (zh) 2007-06-13
CY1118194T1 (el) 2017-06-28
AU2005251556A1 (en) 2005-12-22
RU2006146677A (ru) 2008-07-20
EP1753457A2 (en) 2007-02-21
EP2322173B1 (en) 2016-08-10
DK2322173T3 (en) 2016-12-05
ZA200700169B (en) 2008-05-28
HUE030586T2 (en) 2017-06-28
US8207154B2 (en) 2012-06-26
WO2005120573A2 (en) 2005-12-22
HUE031075T2 (en) 2017-06-28
NO20070083L (no) 2007-03-06
DK1753457T3 (en) 2016-12-05
AU2005251556B2 (en) 2011-04-14
EP2322173A1 (en) 2011-05-18
JP2008501780A (ja) 2008-01-24
ES2602460T3 (es) 2017-02-21
WO2005120573A3 (en) 2006-01-26
CA2569675A1 (en) 2005-12-22
RU2397172C2 (ru) 2010-08-20
BRPI0511909A (pt) 2008-01-15
CN1980661B (zh) 2011-09-28
NZ551845A (en) 2010-08-27
NO20161485A1 (no) 2007-03-06
MXPA06014326A (es) 2007-02-19
US20080076748A1 (en) 2008-03-27
PT2322173T (pt) 2016-11-14
KR101191700B1 (ko) 2012-10-16
CA2569675C (en) 2015-03-17
KR20070026563A (ko) 2007-03-08
PT1753457T (pt) 2016-11-10
EP1753457B1 (en) 2016-08-10
JP5372371B2 (ja) 2013-12-18
NO339304B1 (no) 2016-11-21

Similar Documents

Publication Publication Date Title
CY1118203T1 (el) Κατιονika παραγωγα βακτηριοχλωροφυλλης και χρησεις αυτων
CY1108752T1 (el) Παραγωγα πουρινης δρωντα ως αγωνιστες του α2α-υποδοχεα
DK0754176T3 (da) Hidtil ukendte carbamater og urinstoffer som modifikatorer for multidrugsresistens
CY1117960T1 (el) Φωσφοραμιδικα νουκλεοτιδια ως αντικαρκινικοι παραγοντες
MY198880A (en) Phosphoramidate nucleoside derivatives as anticancer agents
GB0317815D0 (en) Imaging agents
CY1111705T1 (el) Παραγωγα 2-αζα-δικυκλο[3.1.0]εξανιου ως ανταγωνιστες του υποδοχεα ορεξινης
IL204732A (en) @@@@@ - Diplooro - @@ - Deoxy @ tetrahydro uridines, preparations containing them and their use in making @ drugs
EA200601160A1 (ru) 2,6-бисгетероарил-4-аминопиримидины в качестве антагонистов аденозиновых рецепторов
CY1111757T1 (el) Παραγωγα ξανθινης ως εκλεκτικοι αναστολεις ημ74α
MX2010004244A (es) Derivados de imidazo [i,2-a]-piridina utiles como inhibidores de cinasa tipo activina (alk).
CY1107426T1 (el) Νεα παραγωγα φθοριογλυκοσιδιων απο πυραζολες, φαρμακευτικα προϊοντα που περιεχουν τις εν λογω ενωσεις και η χρηση αυτων
CY1111316T1 (el) Νεα παραγωγα 5-υποκατεστημενο 7-αμινο-[1,3]θειαζολο[4,5-d] πυριμιδινης
MY137619A (en) 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
BR112014026730A2 (pt) conjugados fármaco-ligante de dr5
CY1109348T1 (el) Διυδρο-θειενο-πυριμιδινες για τη θεραπεια φλεγμονωδων παθησεων
ATE420117T1 (de) Kovalent an hyaluronsäure oder dessen derivate gebundene taxane
CY1108754T1 (el) Νεα παραγωγα θειοφαινογλυκοσιδης, μεθοδος για την παρασκευη τους, φαρμακα περιεχοντα αυτες τις ενωσεις και η χρηση τους
CY1105621T1 (el) Νεα ετεροκυκλικα παραγωγα φθορογλυκοζιτου, φαρμακα που περιεχουν τις ενωσεις αυτες και η χρηση τους
DK1951729T3 (da) Oxygenbundne pyrimidinderivater
TN2009000180A1 (en) NOVEL 1,4-BENZOTHIEPIN-l,1-DIOXIDE DERIVATIVES WHICH ARE SUBSTITUTED WITH BENZYL GROUPS, METHOD FOR PRODUCING DRUGS CONTAINING SAID COMPOUNDS AND USE THEREOF
TW200630366A (en) Organic compounds
ATE453636T1 (de) Substituierte 2,3-dihydro-1h-isoindol-1-one derivate und anwendungsverfahren
CY1110952T1 (el) Παραγωγα κινουκλιδινης και η χρηση αυτων ως μουσκαρινικοι ανταγωνιστες υποδοχεων μ3
CY1108324T1 (el) Νεοι τεταρτοταγοποιημενοι εστερες κουινουκλιδινης